Crossmark

The importance of children and young person involvement in scoping the need for a paediatric glucocorticoid-associated patient reported outcome measure

Crossref DOI link: https://doi.org/10.1186/s41927-022-00312-9

Published Online: 2022-10-15

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singhal, S. http://orcid.org/0000-0003-1621-3521
Smith, E. M. D. http://orcid.org/0000-0002-8371-7597
Roper, L. http://orcid.org/0000-0002-2918-7628
Pain, C. E. http://orcid.org/0000-0003-4965-3259
Funding

Funding for this research was provided by:

Wellcome Trust
License Information

Text and Data Mining valid from 2022-10-15

Version of Record valid from 2022-10-15
More Information

Article History

Received: 27 March 2022

Accepted: 5 October 2022

First Online: 15 October 2022

Declarations

:

: NHS ethical approval was not required for this PPI initiative as this was a consultation exercise in research design. The UK NHS Health Research Authority differentiates between research consultation where individuals are not research participants but acting as specialist advisors, versus research participation where individuals are the subjects being researched [, ]. Informed written consent was obtained for all participants aged 16 and over. For participants under the age of 16, informed written parental consent was obtained.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below